Oneness Biotech Co., Ltd. (TPEX:4743)
Taiwan · Delayed Price · Currency is TWD 57.30
-1.60 (-2.72%)
Nov 21, 2025, 1:30 PM CST
Oneness Biotech Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | -1,403 | -1,165 | -1,313 | 359.98 | -403.3 | -241.9 | Upgrade |
Depreciation & Amortization | 352.88 | 451.29 | 445.54 | 491.23 | 195.07 | 191.3 | Upgrade |
Other Amortization | 3.12 | 3.12 | 3.46 | 3.41 | 2.27 | 1.32 | Upgrade |
Loss (Gain) From Sale of Assets | -2.44 | 0.03 | -0.26 | - | - | - | Upgrade |
Asset Writedown & Restructuring Costs | 279.19 | 279.7 | - | 0.63 | -6.19 | - | Upgrade |
Loss (Gain) From Sale of Investments | 6.21 | 0.52 | 0.03 | -0.11 | -0.97 | 11.77 | Upgrade |
Loss (Gain) on Equity Investments | 338.61 | 428.9 | 498.78 | -90.02 | -280.31 | -485.93 | Upgrade |
Stock-Based Compensation | 22.42 | 29.31 | 44.43 | 20.34 | 21.71 | 31.9 | Upgrade |
Other Operating Activities | 10.58 | -323.32 | -96.74 | -697.48 | -228.9 | 47.07 | Upgrade |
Change in Accounts Receivable | 0.27 | 10.9 | -12.94 | 1.25 | 453.79 | -12.21 | Upgrade |
Change in Inventory | 5.16 | -1.34 | -19.35 | -31.42 | -31.13 | -4.78 | Upgrade |
Change in Accounts Payable | -1.36 | 0.31 | 0.29 | -0.33 | -39.22 | 50.74 | Upgrade |
Change in Unearned Revenue | -4.53 | -5.39 | 30.08 | -1,010 | - | 555.52 | Upgrade |
Change in Other Net Operating Assets | -60.21 | -54.45 | -2.63 | 71.02 | 28.29 | 13.33 | Upgrade |
Operating Cash Flow | -452.76 | -345.58 | -422.18 | -881 | -288.89 | 158.14 | Upgrade |
Capital Expenditures | -29.55 | -49.71 | -90.06 | -87.35 | -95.35 | -44.82 | Upgrade |
Sale of Property, Plant & Equipment | 1.57 | - | - | - | - | - | Upgrade |
Cash Acquisitions | -25.93 | -25.93 | - | - | - | - | Upgrade |
Sale (Purchase) of Intangibles | -0.64 | -1.17 | -0.86 | -1.84 | -4.95 | -108.45 | Upgrade |
Investment in Securities | 1,228 | 610.24 | -4,747 | 5,797 | 156.12 | -5,555 | Upgrade |
Other Investing Activities | 10.58 | 10.73 | 18.11 | 27.67 | 3.2 | 4.89 | Upgrade |
Investing Cash Flow | 1,186 | 544.16 | -4,820 | 5,736 | 59.54 | -5,703 | Upgrade |
Long-Term Debt Repaid | - | -35.56 | -14.22 | -13.38 | -24.58 | -24.06 | Upgrade |
Net Debt Issued (Repaid) | -42.66 | -35.56 | -14.22 | -13.38 | -24.58 | -24.06 | Upgrade |
Issuance of Common Stock | 25.13 | 55.27 | 257.01 | 344.12 | 516.25 | 5,620 | Upgrade |
Common Dividends Paid | - | - | -39.09 | - | - | - | Upgrade |
Other Financing Activities | - | -0.01 | 182.88 | 121.13 | -147 | - | Upgrade |
Financing Cash Flow | -17.53 | 19.7 | 386.58 | 451.87 | 344.67 | 5,596 | Upgrade |
Foreign Exchange Rate Adjustments | -27.76 | 16.64 | 12.89 | 15.44 | -0 | 0.01 | Upgrade |
Net Cash Flow | 687.73 | 234.93 | -4,842 | 5,322 | 115.32 | 51.08 | Upgrade |
Free Cash Flow | -482.32 | -395.28 | -512.23 | -968.35 | -384.24 | 113.32 | Upgrade |
Free Cash Flow Margin | -411.09% | -335.20% | -590.25% | -90.88% | -584.26% | 272.37% | Upgrade |
Free Cash Flow Per Share | -1.01 | -0.83 | -1.08 | -2.05 | -0.84 | 0.27 | Upgrade |
Cash Interest Paid | 9.11 | 9.61 | 5.61 | 4.6 | 4.9 | 5.18 | Upgrade |
Cash Income Tax Paid | 22.11 | 30.38 | 48.77 | 40.46 | 53.1 | 57.11 | Upgrade |
Levered Free Cash Flow | -256.64 | -320.32 | -359.3 | 381.75 | -44.2 | -788.38 | Upgrade |
Unlevered Free Cash Flow | -250.94 | -314.31 | -355.79 | 384.62 | -41.14 | -785.15 | Upgrade |
Change in Working Capital | -60.66 | -49.97 | -4.54 | -968.98 | 411.73 | 602.61 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.